CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.660 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CureVac N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Why CureVac Stock Leaped 12% Higher Today ↗

June 20, 2023

The war on cancer advances with the German company's latest clinical development.

Via The Motley Fool

DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday ↗

June 20, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma

June 20, 2023

Via ACCESSWIRE

CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board

June 20, 2023

Via ACCESSWIRE

Earnings Preview: CureVac ↗

April 24, 2023

Via Benzinga

CureVac Announces Voting Results of General Meeting

June 19, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023 ↗

June 08, 2023

Via Benzinga

CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update

May 30, 2023

Via ACCESSWIRE

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 23, 2023

Gainers

Via Benzinga

CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech

May 19, 2023

Via ACCESSWIRE

CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK

May 08, 2023

Via ACCESSWIRE

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update

April 25, 2023

Via ACCESSWIRE

CureVac to Report Fourth Quarter and Full-Year 2022 Financial Results and Business Updates on April 25, 2023

April 18, 2023

Via ACCESSWIRE

CureVac Announces Voting Results of Extraordinary General Meeting

March 28, 2023

Via ACCESSWIRE

Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees ↗

February 17, 2023

Shares crumbled after Moderna's flu shot outperformed in just one flu strain.

Via Investor's Business Daily

Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents ↗

February 17, 2023

Via Benzinga

CureVac Announces Closing of $250 million Follow-on Public Offering of Common Shares

February 10, 2023

Via ACCESSWIRE

Why CureVac Shares Are Nosediving Today ↗

February 07, 2023

CureVac BV (NASDAQ: CVAC) shares are trading lower by 13.99% to $9.10 during Tuesday's session after the company announced a proposed public offering of common stock. What Happened?

Via Benzinga

Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket ↗

February 07, 2023

Gainers

Via Benzinga

CureVac Announces Proposed Public Offering of Common Shares

February 07, 2023

Via ACCESSWIRE

CureVac Welcomes Myriam Mendila as New Chief Development Officer

February 01, 2023

Via ACCESSWIRE

CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis(R)

January 31, 2023

Via ACCESSWIRE

CureVac Shares Pop After Encouraging Update From COVID-19, Flu mRNA Vaccine Programs ↗

January 30, 2023

Via Benzinga

CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs

January 30, 2023

Via ACCESSWIRE

The 3 Best Biotech Stocks Under $1 to Buy for January ↗

January 26, 2023

Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.

Via InvestorPlace

Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 19, 2023

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.

Via Benzinga

Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday ↗

January 19, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023 ↗

January 19, 2023

Via Benzinga

Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket ↗

January 19, 2023

Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.

Via Benzinga

Nasdaq, S&P 500 Futures Slump Ahead Of Netflix Earnings, Another Batch Of Economic Data ↗

January 19, 2023

The index futures point to a moderately lower opening for Wall Street stocks on Thursday, as the negative sentiment carries over into the new trading day.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.